Open access
Sep 2026
Stapokibart efficacy by asthma status in chronic rhinosinusitis with nasal polyps: a post hoc analysis of the CROWNS-2 trial
Stapokibart significantly improved NPS, NCS, Lund–Mackay CT score, UPSIT score, loss-of-smell score, TSS, and SNOT-22 score regardless of asthma status at week 24, irrespective of asthma status.
Lin-Ping Shu, Ze-Hua Zhu, Cheng-Shuo Wang et al.
· Asia Pacific Allergy · 0 citations